Logo

Concord Biotech Ltd. Share Price

Concord Biotech Ltd. (INR)2327.460.2   (2.7%)

Exchange ScripsBSE543960NSECONCORDBIOISININE338H01029

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Concord Biotech Ltd. Performance

Market performance
Open price2301.85
High2340
Volumes129256
Prev Close2327.4
Low2276.1
Closing date2025-01-14
Historical performance
1 Year High2664.00
3 Year High2664.00
5 Year High2664.00
1 Year Low1327.05
3 Year Low900.05
5 Year Low900.05

Concord Biotech Ltd. Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
23852
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
79.03
Dividend Yield
Dividend Yield
0.38 %

Concord Biotech Ltd. Investment Returns

1 Year
62.9%
3 Years
N/A
5 Years
N/A
10 Years
N/A

Concord Biotech Ltd. Technicals

IndicatorsValueSignal
5-DMA2286.83Bullish
10-DMA2211.66Bullish
20-DMA2182.4Bullish
50-DMA2080.35Bullish
100-DMA2001.68Bullish
200-DMA1781.96Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters66666
Foreign Investors---------------
Domestic Investors66666
Public Investors84292807318329087480100921
Government---------------

Concord Biotech Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income338353234138
Operating Profit4660383929733417
Interest32986110
Depreciation536540500275
Profit Before Tax4126322023753127
Consolidated Net Profit3081240117492348
Adjusted EPS29231722

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital1051059595
Total Reserves1516212795109379899
Minority Interest------------
Total Non-Current Liabilities319321544774
Total Liabilities17007151401501913127
Capital Work in Progress21151727742179
Total Assets17007151401501913127

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities2655246020751668
Cash Flow from Investing Activities-1546-1580-1118-1952
Cash Flow from Financing Activitie-992-852-1002311
Net Cash Inflow / Outflow11628-4527
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 79.03.
  • 3Y Stock Price CAGR of the stock is 146.9.
  • The stock has a beta of 0.6.
  • In the last financial year, the company had an EBITDA of ₹4660 Million.
  • The company generated revenue of ₹10169 Million in the previous financial year.

Concord Biotech Ltd.

2327.460.2   (2.7%)

Investment Amount: ₹ 139650
Current Value: ₹ 232740
Performance: 66.7%
P/L: ₹ 93090
Top Gainers
SymbolChange%
BRNL47.17(20%)
SURYAROSNI280.05(20%)
ADANIPOWER537(19%)
KHANDSE29.12(19%)
IOB53.77(18%)
Top Losers
SymbolChange%
SABTNL845.05(-10%)
HCLTECH1813.55(-9%)
DNAMEDIA5.8(-8%)
KFINTECH1172.2(-7%)
PRSMJOHNSN152.92(-6%)
UNITDSPR1407.25(-5%)
YAARI13.88(-5%)
TVVISION12.77(-5%)
Similar stocks

Zota Health Care Ltd.

44.3

989.5

December 14 - January 14

Bajaj Healthcare Ltd.

29

545

December 14 - January 14

Medico Remedies Ltd.

23.6

61.98

December 14 - January 14

Brooks Laboratories Ltd.

15.9

174.84

December 14 - January 14

Blue Jet Healthcare Ltd.

15.8

581.4

December 14 - January 14

Biocon Ltd.

9.9

387.65

December 14 - January 14

Gufic Biosciences Ltd.

8.8

469.5

December 14 - January 14

SMS Lifesciences India Ltd.

7.8

1290

December 14 - January 14

Announcing Stock of the Month!

Stock of the Month
Stock of the Month